Roniciclib down-regulates stemness and inhibits cell growth by inducing nucleolar stress in neuroblastoma
Open Access
- 31 July 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 10 (1), 1-16
- https://doi.org/10.1038/s41598-020-69499-6
Abstract
Neuroblastoma, an embryonic tumor arising from neuronal crest progenitor cells, has been shown to contain a population of undifferentiated stem cells responsible for the malignant state and the unfavorable prognosis. Although many previous studies have analyzed neuroblastoma stem cells and their therapeutic targeting, this topic appears still open to novel investigations. Here we found that neurospheres derived from neuroblastoma stem-like cells showed a homogeneous staining for several key nucleolar proteins, such as Nucleolin, Nucleophosmin-1, Glypican-2 and PES-1. We investigated the effects of Roniciclib (BAY 1000394), an anticancer stem cells agent, on neurospheres and on an orthotopic neuroblastoma mouse model, discovering an impressive inhibition of tumor growth and indicating good chances for the use of Roniciclib in vivo. We demonstrated that Roniciclib is not only a Wnt/beta -catenin signaling inhibitor, but also a nucleolar stress inducer, revealing a possible novel mechanism underlying Roniciclib-mediated repression of cell proliferation. Furthermore, we found that high expression of Nucleophosmin-1 correlates with patients' short survival. The co-expression of several stem cell surface antigens such as CD44v6 and CD114, together with the nucleolar markers here described, extends new possibilities to isolate undifferentiated subpopulations from neuroblastoma and identify new targets for the treatment of this childhood malignancy.This publication has 84 references indexed in Scilit:
- Hox-C9 activates the intrinsic pathway of apoptosis and is associated with spontaneous regression in neuroblastomaCell Death & Disease, 2013
- Emerging roles of the neuronal nucleolusTrends in Neurosciences, 2012
- PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegenerationCell Communication and Signaling, 2010
- Selective targeting of neuroblastoma tumour‐initiating cells by compounds identified in stem cell‐based small molecule screensEMBO Molecular Medicine, 2010
- Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN StudyJournal of Clinical Oncology, 2010
- Outcomes for Children and Adolescents With Cancer: Challenges for the Twenty-First CenturyJournal of Clinical Oncology, 2010
- Mutational Heterogeneity in Human Cancers: Origin and ConsequencesAnnual review of pathology, 2010
- Heterogeneity in Cancer: Cancer Stem Cells versus Clonal EvolutionCell, 2009
- Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferationOncogene, 2009
- Inactivation of nucleolin leads to nucleolar disruption, cell cycle arrest and defects in centrosome duplicationBMC Molecular Biology, 2007